BR9408357A - Isolated and purified DNA sequence recombination vector expression vector host vector system pharmaceutical composition isolated and purified mammalian protein dna test and process to produce the same process of suppressing phenotypic neoplastic antibody hybridoma and process for detecting the absence of h protein -nuc in tumor cells - Google Patents

Isolated and purified DNA sequence recombination vector expression vector host vector system pharmaceutical composition isolated and purified mammalian protein dna test and process to produce the same process of suppressing phenotypic neoplastic antibody hybridoma and process for detecting the absence of h protein -nuc in tumor cells

Info

Publication number
BR9408357A
BR9408357A BR9408357A BR9408357A BR9408357A BR 9408357 A BR9408357 A BR 9408357A BR 9408357 A BR9408357 A BR 9408357A BR 9408357 A BR9408357 A BR 9408357A BR 9408357 A BR9408357 A BR 9408357A
Authority
BR
Brazil
Prior art keywords
isolated
purified
protein
nuc
phenotypic
Prior art date
Application number
BR9408357A
Other languages
Portuguese (pt)
Inventor
Wen-Hwa Lee
Phang-Lang Chen
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of BR9408357A publication Critical patent/BR9408357A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4736—Retinoblastoma protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR9408357A 1993-12-20 1994-12-20 Isolated and purified DNA sequence recombination vector expression vector host vector system pharmaceutical composition isolated and purified mammalian protein dna test and process to produce the same process of suppressing phenotypic neoplastic antibody hybridoma and process for detecting the absence of h protein -nuc in tumor cells BR9408357A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17058693A 1993-12-20 1993-12-20
PCT/US1994/014813 WO1995017198A1 (en) 1993-12-20 1994-12-20 A novel tumor suppressor gene

Publications (1)

Publication Number Publication Date
BR9408357A true BR9408357A (en) 1997-08-26

Family

ID=22620468

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9408357A BR9408357A (en) 1993-12-20 1994-12-20 Isolated and purified DNA sequence recombination vector expression vector host vector system pharmaceutical composition isolated and purified mammalian protein dna test and process to produce the same process of suppressing phenotypic neoplastic antibody hybridoma and process for detecting the absence of h protein -nuc in tumor cells

Country Status (14)

Country Link
EP (1) EP0735889A4 (en)
JP (1) JPH09510343A (en)
CN (1) CN1138295A (en)
AU (1) AU1517495A (en)
BR (1) BR9408357A (en)
CA (1) CA2178745A1 (en)
CZ (1) CZ178396A3 (en)
FI (1) FI962558A0 (en)
HU (1) HUT74413A (en)
NO (1) NO962596L (en)
NZ (1) NZ278745A (en)
PL (1) PL315172A1 (en)
SK (1) SK76896A3 (en)
WO (1) WO1995017198A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747282A (en) * 1994-08-12 1998-05-05 Myraid Genetics, Inc. 17Q-linked breast and ovarian cancer susceptibility gene
CN1054399C (en) * 1997-11-07 2000-07-12 中国科学院上海生物化学研究所 Human gene P53BP3 interacting with anti-cancer gene P53
CA2328499A1 (en) 1998-06-30 2000-01-06 Genset S.A. A nucleic acid encoding a retinoblastoma binding protein (rbp-7) and polymorphic markers associated with said nucleic acid
JP2003506015A (en) * 1999-07-05 2003-02-18 クロップデザイン エン．ヴェー． Arabidopsis CDC7 and CDC27 homologs
WO2001029229A1 (en) * 1999-10-18 2001-04-26 Shanghai Bio Road Gene Development Ltd. Novel polypeptide, human retinoblastoma binding protein 20 and polynucleotide encoding it
CN1333255A (en) * 2000-07-07 2002-01-30 上海博德基因开发有限公司 Novel polypeptide--human retina tumor conjugated protein 19.91 and polynucleotide for encoding said polypeptide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4358535A (en) * 1980-12-08 1982-11-09 Board Of Regents Of The University Of Washington Specific DNA probes in diagnostic microbiology

Also Published As

Publication number Publication date
CN1138295A (en) 1996-12-18
FI962558A (en) 1996-06-19
EP0735889A4 (en) 1999-04-14
HUT74413A (en) 1996-12-30
EP0735889A1 (en) 1996-10-09
JPH09510343A (en) 1997-10-21
AU1517495A (en) 1995-07-10
CZ178396A3 (en) 1997-03-12
CA2178745A1 (en) 1995-06-29
SK76896A3 (en) 1997-02-05
HU9601686D0 (en) 1996-08-28
FI962558A0 (en) 1996-06-19
NO962596D0 (en) 1996-06-19
PL315172A1 (en) 1996-10-14
WO1995017198A1 (en) 1995-06-29
NZ278745A (en) 1997-09-22
NO962596L (en) 1996-08-19

Similar Documents

Publication Publication Date Title
BR9505980A (en) Monoclonal antibody its hybridoma cell line fragment amino acid sequences and DNA pharmaceutical composition process for the production of a monoclonal antibody and its use
BR9508417A (en) Nucleic acid isolated cdna isolated protein isolated expression vector process to detect cancer and pre-lung cancer process to select human specimens for hcaviii protein process to test human cell sample antibody and therapeutic composition
BR9407874A (en) Purified mammalian protein called mitosin biologically active fragment purified mammalian protein isolated nucleic acid molecule expression vector host vector system for production of mitosin antimitosin antibody and process for production of mitosin
ATE142266T1 (en) METHOD FOR TRANSPORTING MOLECULES IN EUKARYOTE CELLS
DK0994728T3 (en) Recombinant antibodies specific for beta-amyloid ends, DNA encoding them, and methods for their use
BR9509890A (en) Polypeptide sequence of DNA or RNA host cell vector and process for producing a polypeptide
BR9401321A (en) Mutein, DNA sequence, vector, cell, compound RNA sequence, process for its preparation, pharmaceutical composition and use.
NO991130D0 (en) Modified amino acids, pharmaceutical preparations containing these compounds and processes for their preparation
DE69207580T2 (en) Procedure for DNA detection
BR9610111A (en) Process culture protection composition for product coating and culture protection mixture
DE69617583D1 (en) In vitro cell culture system
DE69333269D1 (en) EXPRESSION SYSTEM IN MAMMALS FOR HCV PROTEINS
BR9101137A (en) METHOD FOR THE PREPARATION OF A HYBRID VECTOR, PROCESS FOR THE PREPARATION OF A DNA MOLECULE, METHOD FOR THE PREPARATION OF A HOST AND FOR THE PREPARATION OF A POLYPEPTIDE AND METHOD FOR THE PREPARATION OF PURE PSM
NO962921D0 (en) T cell antigen receptor V region proteins and process for their preparation
BR9406957A (en) System and process for improved parameetric geometric modeling
IT1267230B1 (en) CONVEYOR FLOATING CONVEYOR SYSTEM
DE3484377D1 (en) PEPTIDES, PHARMACEUTICAL COMPOSITIONS, GENES, VECTORS, HOST ORGANISMS, METHOD FOR THEIR PRODUCTION AND DIAGNOSTIC REAGENTS.
BR9408357A (en) Isolated and purified DNA sequence recombination vector expression vector host vector system pharmaceutical composition isolated and purified mammalian protein dna test and process to produce the same process of suppressing phenotypic neoplastic antibody hybridoma and process for detecting the absence of h protein -nuc in tumor cells
Steck et al. Growth control in cultured 3T3 fibroblasts II. Molecular properties of a fraction enriched in growth inhibitory activity.
CY1108288T1 (en) ANTIBODIES FOR Mammalian LANGERHANS CELL ANTIGONS AND THEIR USES
Buonassisi et al. Antibodies to the heparan sulfate proteoglycans synthesized by endothelial cell cultures
ATE222654T1 (en) METHOD AND MEANS FOR DETECTING ANTIBODIES TO TREPONEMA PALLIDUM
EP0857780A4 (en) Novel proteins remarkably expressed in liver cancer, genes encoding the same, antibodies against the same, and method for detecting the expression of the same
Gibbons et al. A method for the separation of hybrids of chromatographically identical oligomeric proteins. Use of 3, 4, 5, 6-tetrahydrophthaloyl groups as a reversible" chromatographic handle"
BR9709721A (en) Purified and isolated polynucleotide in a host cell vector process to produce chitanase humama to treat a fungal infection and to reduce the amount of a non-chitanase antifungal chitanase polypeptide fragment in a monoclonal antibody hiridoma cell line and pharmaceutical composition

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B15K Others concerning applications: alteration of classification

Ipc: C07K 14/47 (2006.01), A61K 38/00 (2006.0